Trial Profile
An Open-Label Study to Determine the Pharmacokinetics of a Single Dose of DZNS in Adult Epileptic Patients Experiencing a Seizure Episode for Which Acute Treatment With a Benzodiazepine is Clinically Indicated.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2017
Price :
$35
*
At a glance
- Drugs Diazepam (Primary)
- Indications Seizures
- Focus Pharmacokinetics
- Sponsors Acorda Therapeutics
- 25 Jun 2013 Results presented at the International Congress of the International League Against Epilepsy (ILAE) and International Bureau for Epilepsy (IBE), according to an Acorda Therapeutics media release.
- 03 Apr 2013 Company added as trial sponsor and additional lead trial centre identified as reported by ClinicalTrials.gov.
- 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.